Search results for "MCI"

showing 10 items of 228 documents

Novel inulin-based mucoadhesive micelles loaded with corticosteroids as potential transcorneal permeation enhancers

2017

In this work a new copolymer of inulin (INU) derivatized with ethylendiamine (EDA) and retinoic acid (RA), named INU-EDA-RA, was synthetized, characterized and employed to produce micelles as carriers for topical administration of corticosteroids for the potential treatment of diseases of posterior eye segment. Spectroscopic analysis confirmed a molar derivatization degree of 11.30 and 4.30% in EDA and RA, respectively. INU-EDA-RA micelles are capable of strong mucoadhesive interactions which result time-independent and stable over time but concentration depending. Moreover micelles are able to encapsulate efficiently from 3 to 13% (w/w) of lipophilic drugs, as dexamethasone, triamcinolone …

DrugTriamcinolone acetonideTranscorneal enhancerCell SurvivalSwineAdministration Topicalmedia_common.quotation_subjectTranswellPharmaceutical ScienceMucoadhesionRetinal Pigment Epithelium02 engineering and technologyOcular disease030226 pharmacology & pharmacyMicellePermeabilityCorneaMice03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesPolymeric micelleRetinoic acidCell AdhesionMucoadhesionmedicineCorticosteroidAnimalsHumansDissolution testingOcular topical administrationMicellesmedia_commonDrug CarriersChromatographyDose-Response Relationship DrugChemistryInulinGeneral Medicine021001 nanoscience & nanotechnologyPermeability (electromagnetism)Cattle0210 nano-technologyDrug carrierDrug metabolismBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

The role of polymorphisms occurring in BRCA1/2 genes in determining ovarian cancer risk.

2021

e17551 Background: Ovarian cancer (OC) is the 10th tumor occurring in women, it accounts for 30% of all malignant tumor affecting female genital tract in Italy. There are several factors that contribute to OC development; in 15-25% of cases family history of breast and ovarian cancer represent the main risk factor. It is well known that pathogenic variants (PVs) occurring in BRCA1/2 genes strongly increase the risk of developing OC, ranging from 50% in BRCA1 PVs carriers to 30% in BRCA2 PVs carriers. Recently genetic polymorphism has been shown to increase cancer risk, consequently polymorphisms in BRCA1/2 genes could represent low penetrance susceptibility alleles and contribute to determ…

OncologyFemale circumcisionCancer Researchmedicine.medical_specialtyOncologybusiness.industryInternal medicinemedicineOvarian cancermedicine.diseasebusinessGeneJournal of Clinical Oncology
researchProduct

Low density lipoproteins and human serum albumin as the carriers of squalenoylated drugs: insights from molecular simulations

2018

We have studied the interaction of three clinically promising squalenoylated drugs (gemcitabine-squalene, adenine-squalene, and doxorubicin-squalene) with low-density lipoproteins (LDL) by means of atomistic molecular dynamics simulations. It is shown that all studied squalenoylated drugs accumulate inside the LDL particles. This effect is promoted by the squalene moiety, which acts as an anchor and drives the hydrophilic drugs into the hydrophobic core of the LDL lipid droplet. Our data suggest that LDL particles could be a universal carriers of squalenoylated drugs in the bloodstream. Interaction of gemcitabine-squalene with human serum albumin (HSA) was also studied by ensemble of dockin…

Squalene[PHYS.PHYS.PHYS-BIO-PH]Physics [physics]/Physics [physics]/Biological Physics [physics.bio-ph]Drug CompoundingPharmaceutical ScienceSerum Albumin Human02 engineering and technologyPlasma protein bindingMolecular Dynamics Simulation010402 general chemistry01 natural sciencesMolecular Docking SimulationDeoxycytidineSqualenechemistry.chemical_compound[ PHYS.PHYS.PHYS-BIO-PH ] Physics [physics]/Physics [physics]/Biological Physics [physics.bio-ph]Lipid dropletDrug DiscoverymedicineMoietyHumansComputingMilieux_MISCELLANEOUSDrug CarriersBinding SitesAdenine[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences021001 nanoscience & nanotechnologyHuman serum albuminGemcitabine3. Good health0104 chemical sciences[CHIM.THEO]Chemical Sciences/Theoretical and/or physical chemistryLipoproteins LDLMolecular Docking Simulation[ SDV.SP ] Life Sciences [q-bio]/Pharmaceutical scienceschemistryDocking (molecular)Doxorubicin[ CHIM.THEO ] Chemical Sciences/Theoretical and/or physical chemistryBiophysicsMolecular MedicineNanoparticles0210 nano-technologyDrug carrierHydrophobic and Hydrophilic Interactionsmedicine.drugProtein Binding
researchProduct

MILD COGNITIVE IMPAIRMENT (MCI): LA ZONA GRIGIA

2008

MCI ANZIANO DEFICIT COGNITIVO
researchProduct

The inconspicuous penis in children

2015

The term 'inconspicuous penis' refers to a group of anatomical abnormalities in which the penis looks smaller than is expected. Micropenis can be defined as 'true micropenis' - which results from a defect in the hypothalamic-pituitary-gonadal axis - and 'micropenis secondary to congenital anatomical anomalies of the surrounding and overlying structures' - also known as 'concealed penis'. The different forms of concealed penis include webbed penis, congenital megaprepuce and partially hidden penis caused by prepubic adiposity. This disorder can also have iatrogenic causes resulting from adhesions that are secondary to circumcision - this type of concealed penis is known as 'trapped penis'. H…

MaleSex DifferentiationUrologyCongenital megaprepucePenile DiseasesmedicineHumansReconstructive Surgical ProcedureLigamentLigamentsbusiness.industryMedicine (all)Webbed penisAnatomyMicropenisConcealed penisPlastic Surgery Proceduresmedicine.diseasePenimedicine.anatomical_structureSexual dysfunctionCircumcision Malemedicine.symptomGenital Diseases MaleMale factor infertilitybusinessPenisPenisHuman
researchProduct

The use of topical corticosteroides in the treatment of oral lichen planus in Spain: A national survey

2017

Background Explore the treatment of oral lichen planus with topical corticosteroids by the healthcare professionals in Spain. Material and Methods A questionnaire targeted health professionals who treat OLP, in particular maxillofacial surgeons, dermatologist and dentist. The dissemination of the questionnaires was conducted through professional associations and dental and medical societies. The questionnaire was previously evaluated by means of a cognitive pre-test procedure to ensure that the questions were opportune and appropriate, understandable and acceptable among the professionals. Results Of the 890 questionnaires sent a total of 190 questionnaires were answered by 90 dentists, 60 …

medicine.medical_specialtyTriamcinolone acetonideAdministration TopicaleducationMEDLINEDentistry030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineCombined treatmentstomatognathic systemMedicineHumans030212 general & internal medicinePractice Patterns Physicians'skin and connective tissue diseasesGeneral DentistryGlucocorticoidsMaxillofacial surgeonsOral Medicine and Pathologyintegumentary systemHealth professionalsbusiness.industryResearch:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologystomatognathic diseasesOtorhinolaryngologyTopical corticosteroidSpainHealth Care SurveysUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusTreatment timeSelf Reportbusinessmedicine.drugLichen Planus Oral
researchProduct

Optical quality of hyperopic and myopic phakic intraocular lenses

2013

Aims: To assess and compare the optical quality of the myopic and hyperopic implantable collamer lens (ICL) from its wavefront aberrations for different powers and pupil diameters. Settings and Design: Prospective study. Material and Methods: The wavefront aberrations of two myopic (−3 and −6 diopters (D)) and two hyperopic V4b ICLs (+3 and +6D) were measured in vitro . To assess and compare the optical quality of different powers of ICLs, we analyzed the root mean square (RMS) of total higher order aberrations (HOAs), trefoil, coma, tetrafoil, secondary astigmatism, and spherical aberration at 3- and 4.5-mm pupil. In addition, the point spread functions (PSFs) of each ICL evaluated were ca…

steep corneal curvatureintravitreallacrimal fossaRefractive errorvisual acuitygenetic structurespterygium surgerystandard automated perimetryComa (optics)BlindnessPhakic intraocular lenslaw.inventionsubconjunctival bevacizumab injectionCorneaLens Implantation Intraocularlcsh:Ophthalmologylawmodified deep anterior lamellar keratoplastyMitomycin CMaterials TestingAutogenous tissue graftingProspective StudiesDioptreoptical qualityshort wave automated perimetryexcimer lasernon-proliferative diabetic retinopathyMean deviationin vitroheavy silicone oilBevacizumabLens (optics)Aberrations of the eyeSpherical aberrationHyperopiaAntimicrobial effectOriginal ArticleTriamcinolone acetonidehuman trabecular meshwork cellsPhakic Intraocular Lensesmedicine.medical_specialtyImaging in glaucomadisability evaluationconventional silicone oiltriamcinoloneProsthesis DesignKeratoconusphotorefractive keratectomyOphthalmologygrowth factorsmedicineHumansmyopiamyopic implantable collamer lensshort fluctuationsWavefrontmacular edemaoptical coherence tomographyendophthalmitis agentsbusiness.industrybranch retinal vein occlusionretinal nerve fiber layerpterygium recurrencemedicine.diseaseeye diseasesOphthalmologypediatricwavefront aberrationsquality of lifelcsh:RE1-994bypass surgeryHyperopic implantable collamer lenslacrimal drainage systemsense organsbusinessIndian Journal of Ophthalmology
researchProduct

Intravesical gemcitabine in superficial bladder tumours preliminary results of a phase I-II study

2003

INTRODUCTION & OBJECTIVES: Gemcttabme is a pro-drug requmng intracellular phosphorylation by deoxycytidine kinase to be activated. Preliminary experiences. suggesting the activtty and the good tolerability of the drug on superficial transitional cell carcinoma of the bladder (TCCB) when administered by intravesical route, have been recently published. The mm of the present study was to evaluate the ablative efftcacy of weekly intravesical instillations of gemcitabine against paptllary marker lesions left after TUR of superficial TCCB. The scientific background and the ethical acceptability of thts approach have been balidated by the European Organization for Research and Treatment ot Cancer…

bladder tumour gemcitabineSettore MED/24 - Urologia
researchProduct

Cetuximab in small bowel adenocarcinoma: a new friend?

2010

Sir, Small bowel adenocarcinoma (SBA) is a rare and aggressive tumour. SBA in the United States increased from 5.7 cases per million in 1973 to 7.3 cases per million in 2004 (Surveillance Epidemiology and End Results (SEER), 1973–2004 database; Jemal et al (2009). Surgery is the mainstay of treatment, even if chemotherapy in advanced disease has been associated with an increased survival. The most effective agents include 5-FU, irinotecan, platinum agents and gemcitabine (Fishman et al, 2006; Speranza et al, 2010). The molecular characterisation of this cancer could help to improve prognosis. Specifically, the frequency of KRAS gene mutations is similar than in colorectal cancer (Ari et al,…

MaleOncologyIntestinal NeoplasmCancer Researchmedicine.medical_specialtySurvivalSettore MED/06 - Oncologia MedicaColorectal cancerAdenocarcinoma; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Combined Modality Therapy; Female; Humans; Immunotherapy; Intestinal Neoplasms; Intestine Small; Male; Middle Aged; Survival; Oncology; Cancer ResearchCetuximabAdenocarcinomaGene mutationAntibodies Monoclonal Humanizedmedicine.disease_causeAntineoplastic AgentInternal medicineIntestine SmallmedicineAntineoplastic Combined Chemotherapy ProtocolCetuximabbusiness.industryAntibodies MonoclonalCancerMiddle Agedmedicine.diseaseCombined Modality TherapyGemcitabineSurgeryIrinotecanOncologyFOLFIRICamptothecinFemaleImmunotherapyKRASbusinessHumanmedicine.drug
researchProduct

Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis

2020

Combination regimens have shown superiority over single agents in the adjuvant treatment of resected pancreatic cancer (PC), but there are no data supporting definition of the best regimen. This work aimed to compare the efficacy and safety of mFOLFIRINOX, gemcitabine+capecitabine, and gemcitabine+nab/paclitaxel in PC patients. A meta-analysis was performed for direct comparison between trials comparing combination regimens and gemcitabine monotherapy. Subsequently, an indirect comparison was made between trials investigating the efficacy and safety of mFOLFIRINOX, gemcitabine+capecitabine, and gemcitabine+nab/paclitaxel because of the same control arm (gemcitabine). A total of three studie…

OncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentReviewNeutropenialcsh:RC254-282Capecitabine03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePancreatic cancerInternal medicinemedicineChemotherapyMeta-analysi030212 general & internal medicineAdjuvantChemotherapybusiness.industryMFOLFIRINOXPancreatic cancerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseGemcitabineRegimenMeta-analysisOncologyPaclitaxelchemistryAdjuvant Chemotherapy Meta-analysis MFOLFIRINOX Pancreatic cancer Systematic review030220 oncology & carcinogenesisSystematic reviewbusinessAdjuvantmedicine.drug
researchProduct